Laboratory products
DECODING 21 CFR PART 11
Nov 01 2007
Author: S. Raghuraman and Dr. Lai Weng Chuen on behalf of Eutech Instruments Pte Ltd
The 21 CFR Part 11 was effected in 1997 by the US Food & Drug Administration (FDA) to encourage wider use of electronic data technology. With predicate regulations such as GMP, GLP and GCP as its base, Part 11 delineates a set of criteria to implement control, validation and audit trail on electronic data that are meant to replace written documents as equivalents. Although necessary to preserve data integrity, Part 11 remains one of the most challenging regulations imposed by the FDA on the biotechnological and pharmaceutical industries, directly affecting all systems that generate, store and use electronic data which fall under the predicate regulations. In August 2003, after gathering significant industry feedback, FDA released the guidance draft ?Industry Guide, Part 11, Electronic Records; Electronic Signatures ? Scope and Application?. Through this scope and Application Guide, the agency announced a narrowed scope of Part 11 with enforcement discretion exercised on items such as computerised systems validation, time-stamped audit trails, and methods used to reproduce and retain electronic records. This guide remains relevant today, pending a revised version of the Part 11 regulation to be released by FDA.
Digital Edition
ILM 50.2 March 2025
March 2025
Chromatography Articles - Effects of small deviations in flow rate on GPC/SEC results Mass Spectrometry & Spectroscopy Articles - Waiting for the present to catch up to the future: A bette...
View all digital editions
Events
Mar 17 2025 Milan, Italy
Mar 18 2025 Beijing, China
Mar 20 2025 Brussels, Belgium
Mar 20 2025 Chandigarh, India
ACS National Meeting & Expo, Spring 2025
Mar 23 2025 San Diego, CA, USA